IP Library Granted Patent US 8,987,198
Granted Patent B2
US 8,987,198 · App. 12/976,209 · Granted Mar 24, 2015

Compositions and methods for treating obesity and diabetes

Inventors: Matthew E. Burow (Slidell, LA); Stephen M. Boue (New Orleans, LA); Thomas T. Y. Wang (Beltsville, MD); Deepak Bhatnagar (New Orleans, LA); Charles E. Wood (Winston-Salem, NC); Mark L. Helman (New Orleans, LA)
Assignees: The Administrators of the Tulane Educational Fund; The United States Department of Agriculture; Wake Forest University Health Sciences; Nume Health, LLC
A61K31/352A61K31/52A61K38/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,987,198
App. No.
12/976,209
Granted
Mar 24, 2015
Kind
B2
Abstract

Disclosed are methods of modulating the expression of genes linked to adipocytokine signaling, carbohydrate metabolism, fatty acid metabolism, arachidonic acid metabolism, PPAR signaling, insulin signaling, lipid metabolism, extracellular matrix (ECM)-receptor interaction, or combinations thereof, methods of treating hyperlipidemia, obesity, excessive cholesterol, cardiovascular disease, liver disease, diabetes, or combinations thereof, and methods of stimulating glucose uptake in an animal in need thereof, comprising administering a composition comprising at least one isolated glyceollin to said animal.

Claims (9)

1. A method of treating hyperlipidemia, obesity, excessive cholesterol, diabetes, or combinations thereof, in an animal in need thereof, comprising administering a composition comprising at least one isolated glyceollin to said animal, wherein said isolated glyceollin is present in said composition in an amount of from about 100 nM to about 50 μM.

2. The method of claim 1 , wherein said at least one isolated glyceollin is isolated from elicited soy, and is glyceollin I, glyceollin II, glyceollin III, or combinations thereof.

3. The method of claim 2 , wherein said at least one isolated glyceollin is provided in an amount of from about 1 mg/kg/animal to about 100 mg/kg/animal.

4. A method of stimulating glucose uptake in an animal in need thereof, comprising administering a composition comprising at least one isolated glyceollin to said animal wherein said at least one isolated glyceollin is provided in a concentration of from about 100 nM to about 50 μM.

5. The method of claim 4 , wherein said at least one isolated glyceollin is isolated from elicited soy, and is glyceollin I, glyceollin II, glyceollin III, or combinations thereof.

6. The method of claim 4 , wherein said composition further comprises insulin, or wherein a further composition comprising insulin is also administered to said animal.

7. A method of stimulating glucose uptake in an animal in need thereof, comprising administering a composition comprising at least one isolated glyceollin to said animal wherein said at least one isolated glyceollin is provided in an amount of from about 1 mg/kg/animal to about 100 mg/kg/animal.

8. The method of claim 7 , wherein said at least one isolated glyceollin is isolated from elicited soy, and is glyceollin I, glyceollin II, glyceollin III, or combinations thereof.

9. The method of claim 7 , wherein said composition further comprises insulin, or wherein a further composition comprising insulin is also administered to said animal.

Assignments (3)
CHANGE OF NAME Recorded Feb 18, 2015
From: NUME HEALTH LLC
To: MICROBIOME THERAPEUTICS LLC
Reel/Frame 035022/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2015
From: BUROW, MATHEW E.
To: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
Reel/Frame 034961/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2012
From: HEIMAN, MARK L.
To: NUME HEALTH, LLC
Reel/Frame 028372/0842 →
Continuity (3)
Provisional Application 61284623 · Dec 22, 2009
Provisional Application 61399224 · Jul 8, 2010
Related Publication 20110237505A1 · Sep 29, 2011